Team:Hong Kong HKUST/results

From 2013.igem.org

(Difference between revisions)
Line 206: Line 206:
</div>
</div>
<br><br><br>
<br><br><br>
-
<div id="slide"><center><h3 class="title">Result</h3></center>
+
<div id="slide"><center><h3 class="title">Result</h3></center><br><br>
<p id="yo">Our project was first proposed in mid-March and after a series of improvement and elaboration, we started our wet lab work from mid-June to late-September. After 3 months of memorable diligent work, we are proud to claim that we have achieved the results below:
<p id="yo">Our project was first proposed in mid-March and after a series of improvement and elaboration, we started our wet lab work from mid-June to late-September. After 3 months of memorable diligent work, we are proud to claim that we have achieved the results below:
<ul>
<ul>

Revision as of 12:06, 26 September 2013




Result



Our project was first proposed in mid-March and after a series of improvement and elaboration, we started our wet lab work from mid-June to late-September. After 3 months of memorable diligent work, we are proud to claim that we have achieved the results below:

  • Successfully construct the two parts for mitochondria leader sequence, MLS with RFC 10 and RFC 25, (BBa_K1119000, BBa_K1119001).
  • Successfully construct the part of aceA and aceB for in glyoxylate shunt (BBa_K1119002, BBa_K1119003).
  • Successfully construct the part of a constitutive regulatory promoter, Human Elongation Factor 1-alpha promoter (BBa_K1119004).
  • Successfully construct the part for a constitutive CMV promoter (BBa_K1119006).
  • Successfully characterized the regulatory promoter pCMV in HEK293FT cells (BBa_K1119008).
  • Successfully characterized the mitochondria leader sequence MLS in HEK293FT cells (BBa_K1119009).
  • Successfully tested the HepG2 cell viability in different sodium palmitate concentrations.